ZD6474 to Treat Advanced Brain Cancer in Patients

NCT00272350 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

83

Enrollment

NIH

Sponsor class

Conditions

Recurrent High-Grade Gliomas
Progressive Low-Grade Gliomas
Malignant Gliomas

Interventions

DRUG: Steroids
DRUG: ZD6474

Sponsor

National Cancer Institute (NCI)